{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:21:06Z","timestamp":1793038866584,"version":"4.5.0"},"reference-count":313,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"am","delay-in-days":192,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.preteyeres.2021.101018","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T21:25:24Z","timestamp":1636406724000},"page":"101018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)"],"prefix":"10.1016","volume":"88","author":[{"given":"Andrew SH.","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Da","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Chun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala","family":"Al-Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5785-817X","authenticated-orcid":false,"given":"Nita","family":"Valikodath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3630-2142","authenticated-orcid":false,"given":"Vivien L.","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8172-7636","authenticated-orcid":false,"given":"Michael F.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1971-2249","authenticated-orcid":false,"given":"R.V. Paul","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2021.101018_bib1","doi-asserted-by":"crossref","first-page":"e013366","DOI":"10.1136\/bmjopen-2016-013366","article-title":"Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk","volume":"7","author":"Adams","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.preteyeres.2021.101018_bib2","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41433-018-0151-y","article-title":"Retinopathy of prematurity in the United Kingdom: retreatment rates, visual and structural 1-year outcomes","volume":"32","author":"Adams","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2021.101018_bib3","first-page":"S4","article-title":"Classification of retinopathy of prematurity: from then till now","volume":"31","author":"Agarwal","year":"2018","journal-title":"Community Eye Health"},{"key":"10.1016\/j.preteyeres.2021.101018_bib4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3928\/01913913-20190717-01","article-title":"Training of residents and fellows in retinopathy of prematurity around the world: an international web-based survey","volume":"56","author":"AL-Khaled","year":"2019","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.preteyeres.2021.101018_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3928\/01913913-20210223-01","article-title":"Addressing the third epidemic of retinopathy of prematurity through telemedicine and technology: a systematic review","volume":"58","author":"Al-Khaled","year":"2021","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.preteyeres.2021.101018_bib6","doi-asserted-by":"crossref","first-page":"e0230678","DOI":"10.1371\/journal.pone.0230678","article-title":"Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity","volume":"15","author":"Arima","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2021.101018_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.38.7.397","article-title":"Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia","volume":"38","author":"Ashton","year":"1954","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1056\/NEJMoa023080","article-title":"Oxygen-saturation targets and outcomes in extremely preterm infants","volume":"349","author":"Askie","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2021.101018_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2431-11-6","article-title":"NeOProM: neonatal oxygenation prospective meta-analysis collaboration study protocol","volume":"11","author":"Askie","year":"2011","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.preteyeres.2021.101018_bib10","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2018.5725","article-title":"Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective meta-analysis collaboration","volume":"319","author":"Askie","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.preteyeres.2021.101018_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.4.6.5","article-title":"Computer-based image analysis for plus disease diagnosis in retinopathy of prematurity: performance of the \"i-ROP\" system and image features associated with expert diagnosis","volume":"4","author":"Ataer-Cansizoglu","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bjophthalmol-2014-304984","article-title":"Screening for retinopathy of prematurity (ROP) using wide-angle digital retinal photography by non-ophthalmologists: a systematic review","volume":"99","author":"Athikarisamy","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.5301\/ejo.5000166","article-title":"Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II","volume":"22","author":"Autrata","year":"2012","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.DBP.0000452240.39511.d4","article-title":"Neurodevelopmental outcomes of infants born prematurely","volume":"35","author":"Aylward","year":"2014","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.preteyeres.2021.101018_bib15","first-page":"S103","article-title":"Lack of screening underlies most stage-5 retinopathy of prematurity among cases presenting to a tertiary eye center in India","volume":"53","author":"Azad","year":"2016","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.preteyeres.2021.101018_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jpeds.2014.01.017","article-title":"Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes","volume":"165","author":"Darlow","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.preteyeres.2021.101018_bib17","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/bjophthalmol-2017-311662","article-title":"Efficacy of intravitreal conbercept injection in the treatment of retinopathy of prematurity","volume":"103","author":"Bai","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib18","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ophtha.2007.09.012","article-title":"Pharmacokinetics of intravitreal ranibizumab (Lucentis)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0161-6420(99)00042-1","article-title":"A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity","volume":"107","author":"Banach","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib20","article-title":"The retinopathy of prematurity - Save our site program: analysis of gender and socioeconomic status in a ROP telemedicine program in southern India","volume":"59","author":"Beca","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101018_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.earlhumdev.2013.11.002","article-title":"The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial","volume":"90","author":"Beken","year":"2014","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.preteyeres.2021.101018_bib22","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jpen.1497","article-title":"Enteral docosahexaenoic acid and retinopathy of prematurity: a randomized clinical trial","volume":"43","author":"Bernabe-Garcia","year":"2019","journal-title":"JPEN - J. Parenter. Enter. Nutr."},{"key":"10.1016\/j.preteyeres.2021.101018_bib23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/jp.2016.98","article-title":"Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: a significant update","volume":"36","author":"Bharwani","year":"2016","journal-title":"J. Perinatol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib24","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamaophthalmol.2018.2753","article-title":"Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study","volume":"136","author":"Binenbaum","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamaophthalmol.2019.4517","article-title":"Validation of the postnatal growth and retinopathy of prematurity screening criteria","volume":"138","author":"Binenbaum","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamaophthalmol.2018.0649","article-title":"Diagnostic accuracy of ophthalmoscopy vs telemedicine in examinations for retinopathy of prematurity","volume":"136","author":"Biten","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib27","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/j.ophtha.2017.05.007","article-title":"Re: good: Bevacizumab for retinopathy of prematurity: treatment when pathology is embedded in a normally developing vascular system","volume":"124","author":"Blair","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib28","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod. Health"},{"key":"10.1016\/j.preteyeres.2021.101018_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.preteyeres.2021.101018_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmpb.2015.06.004","article-title":"Dealing with inter-expert variability in retinopathy of prematurity: a machine learning approach","volume":"122","author":"Bol\u00f3n-Canedo","year":"2015","journal-title":"Comput. Methods Progr. Biomed."},{"key":"10.1016\/j.preteyeres.2021.101018_bib31","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1056\/NEJMoa1302298","article-title":"Oxygen saturation and outcomes in preterm infants","volume":"368","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2021.101018_bib32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJMoa1514212","article-title":"Outcomes of two trials of oxygen-saturation targets in preterm infants","volume":"374","author":"Boost-II Australia","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2021.101018_bib33","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/IAE.0b013e31815075b0","article-title":"Association of systemic risk factors with the progression of laser-treated retinopathy of prematurity to retinal detachment","volume":"28","author":"Bourla","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5693\/djo.01.2019.08.002","article-title":"The current state of retinopathy of prematurity in India, Kenya, Mexico, Nigeria, Philippines, Romania, Thailand, and Venezuela","volume":"25","author":"Bowe","year":"2019","journal-title":"Digit. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib35","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.oret.2018.02.004","article-title":"OCT angiography in young children with a history of retinopathy of prematurity","volume":"2","author":"Bowl","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/tmj.2020.0010","article-title":"Telemedicine for retinopathy of prematurity","volume":"26","author":"Brady","year":"2020","journal-title":"Telemed. J. e Health"},{"key":"10.1016\/j.preteyeres.2021.101018_bib37","first-page":"CD003665","article-title":"Vitamin E supplementation for prevention of morbidity and mortality in preterm infants","volume":"4","author":"Brion","year":"2003","journal-title":"Cochrane Database Syst Rev, n."},{"key":"10.1016\/j.preteyeres.2021.101018_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00917831","article-title":"Exudative retinopathy of adults: a late sequela of retinopathy of prematurity","volume":"18","author":"Brown","year":"1994","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/jamaophthalmol.2018.1934","article-title":"Automated diagnosis of plus disease in retinopathy of prematurity using deep convolutional neural networks","volume":"136","author":"Brown","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib40","first-page":"366","article-title":"Implementation and evaluation of a tele-education system for the diagnosis of ophthalmic disease by international trainees","author":"Campbell","year":"2015","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.preteyeres.2021.101018_bib41","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.ophtha.2016.04.035","article-title":"Diagnostic discrepancies in retinopathy of prematurity classification","volume":"123","author":"Campbell","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib42","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0161-6420(01)00809-0","article-title":"Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments","volume":"108","author":"Capone","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib43","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ophtha.2019.06.001","article-title":"Are we closer to understanding developmental outcomes from intravitreal bevacizumab therapy for retinopathy of prematurity?","volume":"126","author":"Carden","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib44","first-page":"1215","article-title":"Supplemental oxygen therapy. Basis for noninvasive treatment of retinopathy of prematurity","volume":"36","author":"Chan","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101018_bib45","author":"Chan"},{"key":"10.1016\/j.preteyeres.2021.101018_bib46","first-page":"T2","article-title":"The global education network for retinopathy of prematurity (Gen-Rop): development, implementation, and evaluation of A novel tele-education system (an American ophthalmological society thesis)","volume":"113","author":"Chan","year":"2015","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2021.101018_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","article-title":"Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective","volume":"62","author":"Chan-Ling","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101018_bib48","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1167\/iovs.10-5234","article-title":"Long-term evaluation of refractive status and optical components in eyes of children born prematurely","volume":"51","author":"Chen","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101018_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/2319-4170.110399","article-title":"Retinopathy of prematurity in neonatal patients with birth weight greater than 1500 g in Taiwan","volume":"36","author":"Chen","year":"2013","journal-title":"Biomed. J."},{"key":"10.1016\/j.preteyeres.2021.101018_bib50","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1097\/IAE.0000000000000512","article-title":"Analysis OF changes IN characteristics OF severe retinopathy OF prematurity patients after screening guidelines were issued IN China","volume":"35","author":"Chen","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2016.03.030","article-title":"Outer retinal structural alternation and segmentation errors in optical coherence tomography imaging in patients with a history of retinopathy of prematurity","volume":"166","author":"Chen","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib52","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3928\/23258160-20180129-07","article-title":"Outcomes of intravitreal bevacizumab and diode laser photocoagulation for treatment-warranted retinopathy of prematurity","volume":"49","author":"Chen","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib53","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1097\/IAE.0000000000002754","article-title":"Anatomical and functional results OF intravitreal aflibercept monotherapy for type 1 retinopathy OF prematurity: one-year outcomes","volume":"40","author":"Chen","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib54","doi-asserted-by":"crossref","first-page":"10732","DOI":"10.1038\/s41598-018-28987-6","article-title":"A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity","volume":"8","author":"Cheng","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2021.101018_bib55","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ophtha.2012.01.002","article-title":"Detection of clinically significant retinopathy of prematurity using wide-angle digital retinal photography: a report by the American Academy of Ophthalmology","volume":"119","author":"Chiang","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib56","series-title":"International Classification of Retinopathy of Prematurity","first-page":"2021","author":"Chiang","year":"2021"},{"key":"10.1016\/j.preteyeres.2021.101018_bib57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3341\/kjo.2012.26.4.277","article-title":"Long-term results of lens-sparing vitrectomy for progressive posterior-type stage 4A retinopathy of prematurity","volume":"26","author":"Choi","year":"2012","journal-title":"Kor. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1542\/peds.111.2.339","article-title":"Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?","volume":"111","author":"Chow","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib59","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1001\/archophthalmol.2011.265","article-title":"Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity","volume":"129","author":"Chow","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib60","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1542\/peds.112.6.1415","article-title":"Resolving our uncertainty about oxygen therapy","volume":"112","author":"Cole","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib61","series-title":"Artificial Intelligence in Retina","author":"Cole","year":"2019"},{"key":"10.1016\/j.preteyeres.2021.101018_bib62","article-title":"iTeleGEN: development of a web-based diabetic retinopathy education module","author":"Cole","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101018_bib63","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1056\/NEJMoa1611942","article-title":"Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants","volume":"376","author":"Collins","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2021.101018_bib64","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/archdischild-2011-300093","article-title":"Visual impairment in children in middle- and lower-income countries","volume":"96","author":"Courtright","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.preteyeres.2021.101018_bib65","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results","volume":"106","author":"Cryotherapy For Retinopathy Of Prematurity Cooperative Group","year":"1988","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archopht.1993.01090030057039","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. 3 1\/2-year outcome--structure and function","volume":"111","author":"Cryotherapy For Retinopathy Of Prematurity Cooperative Group","year":"1993","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib67","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archopht.119.8.1129","article-title":"Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity","volume":"119","author":"Cryotherapy For Retinopathy Of Prematurity Cooperative Group","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib68","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archopht.119.8.1110","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years","volume":"119","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib69","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.iae.0000244268.21514.f7","article-title":"Anatomical and visual results of vitreoretinal surgery for stage 5 retinopathy of prematurity","volume":"26","author":"Cusick","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib70","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/archopht.1991.01080100022007","article-title":"Laser photocoagulation for threshold retinopathy of prematurity","volume":"109","author":"Iverson","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib71","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.semperi.2019.05.004","article-title":"Primary prevention of ROP and the oxygen saturation targeting trials","volume":"43","author":"Darlow","year":"2019","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib72","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/bjo.81.11.935","article-title":"Prospective study of New Zealand infants with birth weight less than 1500 g and screened for retinopathy of prematurity: visual outcome at age 7-8 years","volume":"81","author":"Darlow","year":"1997","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib74","first-page":"CD000501","article-title":"Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants","volume":"8","author":"Darlow","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preteyeres.2021.101018_bib75","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bjophthalmol-2017-311345","article-title":"Vision in former very low birthweight young adults with and without retinopathy of prematurity compared with term born controls: the NZ 1986 VLBW follow-up study","volume":"102","author":"Darlow","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib76","series-title":"Retinopathy of Prematurity Stage Diagnosis Using Object Segmentation and Convolutional Neural Networks","author":"Ding","year":"2020"},{"key":"10.1016\/j.preteyeres.2021.101018_bib77","author":"Do No Harm Technical Brief"},{"key":"10.1016\/j.preteyeres.2021.101018_bib78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archopht.124.2.199","article-title":"Visual acuity at 10 years in Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) study eyes: effect of retinal residua of retinopathy of prematurity","volume":"124","author":"Dobson","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000223949","article-title":"Anti-angiogenic therapy in the management of retinopathy of prematurity","volume":"44","author":"Drenser","year":"2009","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.preteyeres.2007.07.005","article-title":"State-of-the-art retinal optical coherence tomography","volume":"27","author":"Drexler","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101018_bib81","doi-asserted-by":"crossref","first-page":"278S","DOI":"10.1093\/advances\/nmy022","article-title":"Overview of nutrients in human milk","volume":"9","author":"Dror","year":"2018","journal-title":"Adv Nutr"},{"key":"10.1016\/j.preteyeres.2021.101018_bib82","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4103\/ijo.IJO_1789_18","article-title":"Prevalence, risk factors and pattern of severe retinopathy of prematurity in eastern Madhya Pradesh","volume":"67","author":"Dwivedi","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib83","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00417-018-4168-5","article-title":"Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity","volume":"257","author":"Sukgen","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib84","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","author":"Early Treatment For Retinopathy Of Prematurity Cooperative Group","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib85","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/08820538.2015.1114847","article-title":"Role of VEGF inhibition in the treatment of retinopathy of prematurity","volume":"31","author":"Eldweik","year":"2016","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib86","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-0389","article-title":"A multifaceted approach to improving outcomes in the NICU: the pediatrix 100000Babies campaign","volume":"137","author":"Ellsbury","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib87","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/jamaophthalmol.2016.3190","article-title":"Malpractice litigation in pediatric ophthalmology","volume":"134","author":"Engelhard","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib88","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2021.101018_bib89","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.ophtha.2019.03.048","article-title":"Neurodevelopmental outcomes after intravitreal bevacizumab therapy for retinopathy of prematurity: a prospective case-control study","volume":"126","author":"Fan","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib90","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3387","article-title":"Interventions to prevent retinopathy of prematurity: a meta-analysis","volume":"137","author":"Fang","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1167\/tvst.9.8.43","article-title":"Ranibizumab population pharmacokinetics and free VEGF pharmacodynamics in preterm infants with retinopathy of prematurity in the RAINBOW trial","volume":"9","author":"Fidler","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib92","doi-asserted-by":"crossref","first-page":"F179","DOI":"10.1136\/archdischild-2014-306207","article-title":"Impact of retinopathy of prematurity on ocular structures and visual functions","volume":"100","author":"Fielder","year":"2015","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"5","key":"10.1016\/j.preteyeres.2021.101018_bib93","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ophtha.2018.12.034","article-title":"Describing retinopathy of prematurity: current limitations and new challenges","volume":"126","author":"Fielder","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib94","unstructured":"Fierson, W. M.; Ophthalmology, A. A. O. P. S. O.; Ophthalmology, A. A. O.; Strabismus, A. A. F. P. O. A. et al. 2013. Screening examination of premature infants for retinopathy of prematurity. Pediatrics, 131, 189-195."},{"key":"10.1016\/j.preteyeres.2021.101018_bib95","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1542\/peds.2014-0978","article-title":"Telemedicine for evaluation of retinopathy of prematurity","volume":"135","author":"Fierson","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib96","unstructured":"Fierson, W. M.; Ophthalmology, A. A. O. P. S. O.; Ophthalmology, A. A. O.; Strabismus, A. A. F. P. O. A. et al. 2018. Screening Examination of Premature Infants for Retinopathy of Prematurity. Pediatrics, 142, e20183061."},{"key":"10.1016\/j.preteyeres.2021.101018_bib97","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1755-3768.1980.tb08314.x","article-title":"Ophthalmic changes from age of 10 to 18 years. A longitudinal study of sequels to low birth weight. I. Refraction","volume":"58","author":"Fledelius","year":"1980","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib98","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1755-3768.1981.tb06712.x","article-title":"Ophthalmic changes from age of 10 to 18 years. A longitudinal study of sequels to low birth weight. II. Visual acuity","volume":"59","author":"Fledelius","year":"1981","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib99","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1600-0420.1996.tb00094.x","article-title":"Pre-term delivery and subsequent ocular development. A 7-10 year follow-up of children screened 1982-84 for ROP. 1) Visual function, slit-lamp findings, and fundus appearance","author":"Fledelius","year":"1996","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.preteyeres.2021.101018_bib100","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1167\/iovs.09-4065","article-title":"Alterations in the intraocular cytokine milieu after intravitreal bevacizumab","volume":"51","author":"Forooghian","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101018_bib101","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0002-9394(14)72160-9","article-title":"Long-term follow up of visual acuity in eyes with stage 5 retinopathy of prematurity after closed vitrectomy","volume":"120","author":"Fuchino","year":"1995","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib102","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.preteyeres.2009.06.003","article-title":"The neurovascular retina in retinopathy of prematurity","volume":"28","author":"Fulton","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101018_bib103","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.ophtha.2018.06.001","article-title":"Systemic effects of Optos versus indirect ophthalmoscopy for retinopathy of prematurity screening","volume":"125","author":"Fung","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib104","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00417-015-3197-6","article-title":"Minimally fibrotic stage 5 ROP: a clinical prognostic factor in eyes undergoing vitrectomy for stage 5 retinopathy of prematurity","volume":"254","author":"Gadkari","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jaapos.2007.09.005","article-title":"Plus disease in retinopathy of prematurity: pilot study of computer-based and expert diagnosis","volume":"11","author":"Gelman","year":"2007","journal-title":"J Aapos"},{"key":"10.1016\/j.preteyeres.2021.101018_bib106","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.preteyeres.2021.101018_bib107","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs","volume":"115","author":"Gilbert","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib108","doi-asserted-by":"crossref","first-page":"F6","DOI":"10.1136\/archdischild-2015-308704","article-title":"Potential for a paradigm change in the detection of retinopathy of prematurity requiring treatment","volume":"101","author":"Gilbert","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal"},{"key":"10.1016\/j.preteyeres.2021.101018_bib109","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/aogs.13684","article-title":"Obstetric strategies to reduce blindness from retinopathy of prematurity in infants born preterm","volume":"98","author":"Gilbert","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.preteyeres.2021.101018_bib110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.semperi.2019.05.002","article-title":"Epidemiology of ROP update - Africa is the new frontier","volume":"43","author":"Gilbert","year":"2019","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib111","first-page":"233","article-title":"Early treatment for retinopathy OF prematurity cooperative. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2021.101018_bib112","first-page":"101","article-title":"Surgery for stage 5 retinopathy of prematurity: the learning curve and evolving technique","volume":"48","author":"Gopal","year":"2000","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib113","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4103\/ijo.IJO_1177_18","article-title":"Smartphone guided wide-field imaging for retinopathy of prematurity in neonatal intensive care unit - a Smart ROP (SROP) initiative","volume":"67","author":"Goyal","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib114","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamaophthalmol.2019.2442","article-title":"A quantitative severity scale for retinopathy of prematurity using deep learning to monitor disease regression after treatment","volume":"137","author":"Gupta","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jamaophthalmol.2016.5203","article-title":"A tiered approach to retinopathy of prematurity screening (TARP) using a weight gain predictive model and a telemedicine system","volume":"135","author":"Gurwin","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib116","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.preteyeres.2016.09.004","article-title":"The neural retina in retinopathy of prematurity","volume":"56","author":"Hansen","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101018_bib117","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1651-2227.2011.02445.x","article-title":"On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment - a review","volume":"100","author":"Hard","year":"2011","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.preteyeres.2021.101018_bib118","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/heapol\/czy004","article-title":"Reducing blindness from retinopathy of prematurity (ROP) in Argentina through collaboration, advocacy and policy implementation","volume":"33","author":"Hariharan","year":"2018","journal-title":"Health Pol. Plann."},{"key":"10.1016\/j.preteyeres.2021.101018_bib119","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","article-title":"Pathophysiology and mechanisms of severe retinopathy of prematurity","volume":"122","author":"Hartnett","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib120","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2021.101018_bib121","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","article-title":"Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth","volume":"112","author":"Hellstr\u00f6m","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib122","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1542\/peds.2008-2697","article-title":"Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening","volume":"123","author":"Hellstr\u00f6m","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib123","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1651-2227.2009.01568.x","article-title":"New insights into the development of retinopathy of prematurity--importance of early weight gain","volume":"99","author":"Hellstr\u00f6m","year":"2010","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.preteyeres.2021.101018_bib124","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2021.101018_bib125","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamaophthalmol.2013.135","article-title":"Plus disease in retinopathy of prematurity: qualitative analysis of diagnostic process by experts","volume":"131","author":"Hewing","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib126","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clp.2019.05.008","article-title":"Oxygen saturation and retinopathy of prematurity","volume":"46","author":"Higgins","year":"2019","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib127","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1203\/00006450-200112000-00017","article-title":"Physical growth and retinopathy in preterm infants: involvement of IGF-I and GH","volume":"50","author":"Hikino","year":"2001","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.preteyeres.2021.101018_bib128","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1097\/IAE.0b013e31820d3f70","article-title":"Management of avascular peripheral retina in older prematurely born infants","volume":"31","author":"Ho","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib129","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clp.2013.02.008","article-title":"Outcome of retinopathy of prematurity","volume":"40","author":"Holmstr\u00f6m","year":"2013","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3928\/01913913-20061101-04","article-title":"Prevalence and development of strabismus in 10-year-old premature children: a population-based study","volume":"43","author":"Holmstr\u00f6m","year":"2006","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.preteyeres.2021.101018_bib131","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/aos.13549","article-title":"Increased frequency of retinopathy of prematurity over the last decade and significant regional differences","volume":"96","author":"Holmstr\u00f6m","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib132","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2016.4396","article-title":"Variation in performance of neonatal intensive care units in the United States","volume":"171","author":"Horbar","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.preteyeres.2021.101018_bib133","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3389\/fphys.2019.00961","article-title":"Postnatal nutrition to improve brain development in the preterm infant: a systematic review from bench to bedside","volume":"10","author":"Hortensius","year":"2019","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.preteyeres.2021.101018_bib134","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection [published correction appears in Arch Ophthalmol. 2013 Feb;131(2):212]","volume":"130","author":"Hu","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib135","first-page":"5078565","article-title":"Recurrence of retinopathy of prematurity in zone II stage 3+ after ranibizumab treatment: a retrospective study","author":"Hu","year":"2017","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib136","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00417-017-3878-4","article-title":"Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity","volume":"256","author":"Huang","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib137","article-title":"Cumulative evidence for association of sepsis and retinopathy of prematurity","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.preteyeres.2021.101018_bib138","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/IAE.0000000000001908","article-title":"Impact OF etiology ON the outcome OF pediatric rhegmatogenous retinal detachment","volume":"39","author":"Huang","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib139","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/bjophthalmol-2019-314860","article-title":"Prediction of visual outcomes by an artificial neural network following intravitreal injection and laser therapy for retinopathy of prematurity","volume":"104","author":"Huang","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib140","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/bjophthalmol-2020-316526","article-title":"Automated detection of early-stage ROP using a deep convolutional neural network","volume":"105","author":"Huang","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib141","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ophtha.2015.11.003","article-title":"Clinical models and algorithms for the prediction of retinopathy of prematurity: a report by the American Academy of ophthalmology","volume":"123","author":"Hutchinson","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib142","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archopht.1987.01060070042025","article-title":"An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity","volume":"105","author":"Icrop","year":"1987","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib143","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","author":"International Classification Of Retinopathy Of Prematurity","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib144","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archopht.126.4.493","article-title":"Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management","volume":"126","author":"Jackson","year":"2008","journal-title":"Arch. Ophthalmol."},{"issue":"5","key":"10.1016\/j.preteyeres.2021.101018_bib318","doi-asserted-by":"crossref","first-page":"676","DOI":"10.5535\/arm.2015.39.5.676","article-title":"Neuropsychological Outcomes of Preterm Birth in Children With No Major Neurodevelopmental Impairments in Early Life","volume":"39","author":"Joo","year":"2015","journal-title":"Ann. Rehabil. Med."},{"key":"10.1016\/j.preteyeres.2021.101018_bib145","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0161-6420(01)00660-1","article-title":"Adult retinopathy of prematurity: outcomes of rhegmatogenous retinal detachments and retinal tears","volume":"108","author":"Kaiser","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib146","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1542\/peds.2007-2725","article-title":"Cost-effectiveness of early treatment for retinopathy of prematurity","volume":"123","author":"Kamholz","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib147","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1097\/IAE.0b013e31828e6969","article-title":"The use of digital imaging in the identification of skip areas after laser treatment for retinopathy of prematurity and its implications for education and patient care","volume":"33","author":"Kang","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib148","article-title":"Characterization of errors in retinopathy of prematurity (ROP) diagnosis by international ophthalmology residents","volume":"57","author":"Kang","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101018_bib149","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.survophthal.2018.09.002","article-title":"The current state of artificial intelligence in ophthalmology","volume":"64","author":"Kapoor","year":"2019","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib150","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjophthalmol-2016-309198","article-title":"Long-term functional results following vitrectomy for advanced retinopathy of prematurity","volume":"101","author":"Karacorlu","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib151","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1111\/aos.13008","article-title":"Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity","volume":"94","author":"Karkhaneh","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib152","doi-asserted-by":"crossref","first-page":"65","DOI":"10.12688\/gatesopenres.13098.1","article-title":"Building a global policy agenda to prioritize preterm birth: a qualitative analysis on factors shaping global health policymaking","volume":"4","author":"Kassabian","year":"2020","journal-title":"Gates Open Res"},{"key":"10.1016\/j.preteyeres.2021.101018_bib153","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41372-020-00884-9","article-title":"Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis","volume":"41","author":"Kaushal","year":"2021","journal-title":"J. Perinatol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib154","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaapos.2017.10.006","article-title":"Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity","volume":"22","author":"Kennedy","year":"2018","journal-title":"J AAPOS"},{"key":"10.1016\/j.preteyeres.2021.101018_bib155","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","article-title":"Retinopathy of prematurity: a review of risk factors and their clinical significance","volume":"63","author":"Kim","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib156","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archopht.1996.01100130144005","article-title":"Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Cooperative Group","volume":"114","author":"Kivlin","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib157","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/archopht.1982.01030030258004","article-title":"Strabismus and amblyopia associated with regressed retinopathy of prematurity","volume":"100","author":"Kushner","year":"1982","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib158","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(14)77029-1","article-title":"Argon laser photocoagulation for advanced retinopathy of prematurity","volume":"110","author":"Landers","year":"1990","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib159","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1742-4755-10-S1-S5","article-title":"Born too soon: care for the preterm baby","volume":"10","author":"Lawn","year":"2013","journal-title":"Reprod. Health"},{"key":"10.1016\/j.preteyeres.2021.101018_bib160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.siny.2011.08.007","article-title":"Perinatal infection, inflammation, and retinopathy of prematurity","volume":"17","author":"Lee","year":"2012","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.preteyeres.2021.101018_bib161","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00417-010-1355-4","article-title":"Idiopathic maculopathy in eyes with regressed retinopathy of prematurity","volume":"248","author":"Lee","year":"2010","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib162","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajo.2018.05.002","article-title":"Macular structures, optical components, and visual acuity in preschool children after intravitreal bevacizumab or laser treatment","volume":"192","author":"Lee","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib163","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12886-018-0973-1","article-title":"the treatment and risk factors of retinopathy of prematurity in neonatal intensive care units","volume":"18","author":"Leng","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib164","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ophtha.2014.05.015","article-title":"Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings","volume":"121","author":"Lepore","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib165","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2017.08.005","article-title":"Follow-up to age 4 Years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings","volume":"125","author":"Lepore","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148019","article-title":"Neurodevelopmental outcomes in infants with retinopathy of prematurity and bevacizumab treatment","volume":"11","author":"Lien","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2021.101018_bib167","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.semperi.2019.05.008","article-title":"Postnatal weight gain and retinopathy of prematurity","volume":"43","author":"Lin","year":"2019","journal-title":"Semin. Perinatol."},{"issue":"9","key":"10.1016\/j.preteyeres.2021.101018_bib317","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/IAE.0000000000002663","article-title":"Rates and risk factors for recurrence of retinopathy of prematurity after laser or intravitreal anti-vascular endothelial growth factor monotherapy","volume":"40","author":"Ling","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib169","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/archopht.124.12.1711","article-title":"Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity","volume":"124","author":"L\u00f6fqvist","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2010.01.001","article-title":"Novel uses of smartphones in ophthalmology","volume":"117","author":"Lord","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib171","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000448161","article-title":"Aggressive posterior retinopathy of prematurity is associated with multiple infectious episodes and thrombocytopenia","volume":"111","author":"Lundgren","year":"2017","journal-title":"Neonatology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib172","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1167\/iovs.10-6798","article-title":"Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog","volume":"52","author":"Lutty","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101018_bib173","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1167\/iovs.16-20680","article-title":"Recurrence of retinopathy of prematurity after intravitreal ranibizumab monotherapy: timing and risk factors","volume":"58","author":"Lyu","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101018_bib174","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/IAE.0b013e318275394a","article-title":"Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up","volume":"33","author":"Mart\u00ednez-Castellanos","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib175","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00919646","article-title":"Late traction detachment in retinopathy of prematurity or ROP-like cases","volume":"231","author":"Machemer","year":"1993","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib176","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2008.945","article-title":"Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial","volume":"301","author":"Makrides","year":"2009","journal-title":"Jama"},{"key":"10.1016\/j.preteyeres.2021.101018_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-4642(21)00195-4","article-title":"2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial","author":"Marlow","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.preteyeres.2021.101018_bib178","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archopht.126.7.907","article-title":"Visual insignificance of the foveal pit: reassessment of foveal hypoplasia as fovea plana","volume":"126","author":"Marmor","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib179","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12886-015-0001-7","article-title":"Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone Ii, stage 3 with plus disease","volume":"15","author":"Menke","year":"2015","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2016.04.014","article-title":"The economic model of retinopathy of prematurity (EcROP) screening and treatment: Mexico and the United States","volume":"168","author":"Rothschild","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib181","first-page":"574","article-title":"Vascular endothelial growth factor\/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model","volume":"145","author":"Miller","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib182","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0161-6420(99)00732-0","article-title":"A small foveal avascular zone may be an historic mark of prematurity","volume":"106","author":"Mintz-Hittner","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib183","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2021.101018_bib184","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ophtha.2016.04.028","article-title":"Clinical management of recurrent retinopathy of prematurity after intravitreal bevacizumab monotherapy","volume":"123","author":"Mintz-Hittner","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ajo.2016.12.025","article-title":"Plus disease in retinopathy of prematurity: diagnostic trends in 2016 versus 2007","volume":"176","author":"Moleta","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib186","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/bjophthalmol-2017-310709","article-title":"A worldwide survey of retinopathy of prematurity screening","volume":"102","author":"Mora","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib187","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib188","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/ICU.0000000000000471","article-title":"Top five legal pitfalls in retinopathy of prematurity","volume":"29","author":"Moshfeghi","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib189","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ophtha.2011.04.028","article-title":"Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice","volume":"118","author":"Moshfeghi","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib190","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1001\/archopht.122.12.1816","article-title":"Lens-sparing vitrectomy for progressive tractional retinal detachments associated with stage 4A retinopathy of prematurity","volume":"122","author":"Moshfeghi","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib191","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1542\/peds.113.4.790","article-title":"Educational and social competencies at 8 years in children with threshold retinopathy of prematurity in the CRYO-ROP multicenter study","volume":"113","author":"Msall","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib192","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaapos.2011.06.011","article-title":"Accuracy of retinopathy of prematurity image-based diagnosis by pediatric ophthalmology fellows: implications for training","volume":"15","author":"Myung","year":"2011","journal-title":"J Aapos"},{"key":"10.1016\/j.preteyeres.2021.101018_bib193","first-page":"1236","article-title":"[Summarized results of treatment of acute proliferative retinopathy of prematurity during the past 15 years in Tenri Hospital]","volume":"86","author":"Nagata","year":"1982","journal-title":"Nippon. Ganka Gakkai Zasshi"},{"key":"10.1016\/j.preteyeres.2021.101018_bib194","doi-asserted-by":"crossref","first-page":"2644-2645","DOI":"10.1016\/j.ophtha.2012.07.015","article-title":"Retinopathy of prematurity residency training","volume":"119","author":"Nagiel","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib195","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3537","article-title":"Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment","volume":"144","author":"Natarajan","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib196","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0140-6736(88)90820-3","article-title":"Epidemiology of retinopathy of prematurity","volume":"2","author":"Ng","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2021.101018_bib197","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ophtha.2014.11.004","article-title":"Long-term outcomes on lens clarity after lens-sparing vitrectomy for retinopathy of prematurity","volume":"122","author":"Nudleman","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib198","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/archopht.120.6.767","article-title":"Strabismus in children of birth weight less than 1701 g","volume":"120","author":"O'connor","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib199","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1542\/peds.109.1.12","article-title":"Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity","volume":"109","author":"O'connor","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib200","first-page":"355","article-title":"Bevacizumab compared with diode laser in stage 3 posterior retinopathy of prematurity: a 5 year follow up","volume":"109","author":"O'keeffe","year":"2016","journal-title":"Ir. Med. J."},{"key":"10.1016\/j.preteyeres.2021.101018_bib201","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3928\/01913913-20200804-01","article-title":"Development of screening criteria for retinopathy of prematurity in ulaanbaatar, Mongolia, using a web-based data management system","volume":"57","author":"Olson","year":"2020","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.preteyeres.2021.101018_bib202","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaapos.2017.11.005","article-title":"A national telemedicine network for retinopathy of prematurity screening","volume":"22","author":"Ossand\u00f3n","year":"2018","journal-title":"J Aapos"},{"key":"10.1016\/j.preteyeres.2021.101018_bib203","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(91)32074-8","article-title":"Incidence and early course of retinopathy of prematurity. The cryotherapy for retinopathy of prematurity cooperative group","volume":"98","author":"Palmer","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib204","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archopht.123.3.311","article-title":"15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity","volume":"123","author":"Palmer","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/tmj.2015.0068","article-title":"Fundus photography in the 21st century--A review of recent technological advances and their implications for worldwide healthcare","volume":"22","author":"Panwar","year":"2016","journal-title":"Telemed. J. e Health"},{"key":"10.1016\/j.preteyeres.2021.101018_bib206","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00006982-200406000-00006","article-title":"Retinal detachment of regressed retinopathy of prematurity in children aged 2 to 15 years","volume":"24","author":"Park","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib207","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/eye.2013.45","article-title":"Non-contact ultra-widefield imaging of retinopathy of prematurity using the Optos dual wavelength scanning laser ophthalmoscope","volume":"27","author":"Patel","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2021.101018_bib208","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ophtha.2017.02.014","article-title":"Assessment of a tele-education system to enhance retinopathy of prematurity training by international ophthalmologists-in-training in Mexico","volume":"124","author":"Patel","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib209","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/IAE.0b013e3181c9696a","article-title":"Accuracy of retinopathy of prematurity diagnosis by retinal fellows","volume":"30","author":"Paul Chan","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib210","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0148607113499373","article-title":"Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study","volume":"38","author":"Pawlik","year":"2014","journal-title":"JPEN - J. Parenter. Enter. Nutr."},{"key":"10.1016\/j.preteyeres.2021.101018_bib211","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1203\/00006450-199412000-00007","article-title":"Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat","volume":"36","author":"Penn","year":"1994","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.preteyeres.2021.101018_bib212","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bjophthalmol-2019-314429","article-title":"Visual function is reduced in young adults formerly born prematurely: a population-based study","volume":"104","author":"P\u00e9tursd\u00f3ttir","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib213","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/jamaophthalmol.2019.4502","article-title":"Individual risk prediction for sight-threatening retinopathy of prematurity using birth characteristics","volume":"138","author":"Pivodic","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib214","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMe1305534","article-title":"Oxygen-saturation targets in preterm infants","volume":"368","author":"Polin","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2021.101018_bib215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/EB.S94436","article-title":"Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemic","volume":"8","author":"Quinn","year":"2016","journal-title":"Eye Brain"},{"key":"10.1016\/j.preteyeres.2021.101018_bib216","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0161-6420(98)97036-1","article-title":"Prevalence of myopia between 3 months and 5 1\/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"105","author":"Quinn","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib217","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/archophthalmol.2010.360","article-title":"Visual field extent at 6 years of age in children who had high-risk prethreshold retinopathy of prematurity","volume":"129","author":"Quinn","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib219","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2014.1604","article-title":"Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity","volume":"132","author":"Quinn","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib220","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaophthalmol.2016.3502","article-title":"Analysis of discrepancy between diagnostic clinical examination findings and corresponding evaluation of digital images in the telemedicine Approaches to evaluating acute-phase retinopathy of prematurity study","volume":"134","author":"Quinn","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib221","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jamaophthalmol.2018.4290","article-title":"Incidence and early course of retinopathy of prematurity: secondary analysis of the postnatal growth and retinopathy of prematurity (G-ROP) study","volume":"136","author":"Quinn","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib222","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/archopht.125.11.1495","article-title":"Progression to severe retinopathy predicted by retinal vessel diameter between 31 and 34 weeks of postconception age","volume":"125","author":"Rabinowitz","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib223","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41372-019-0420-z","article-title":"Neurodevelopmental outcomes in infants treated with intravitreal bevacizumab versus laser","volume":"39","author":"Raghuram","year":"2019","journal-title":"J. Perinatol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib224","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0022-3476(97)70031-3","article-title":"Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials","volume":"131","author":"Raju","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.preteyeres.2021.101018_bib225","first-page":"451","article-title":"Multiple instance learning: robust validation on retinopathy of prematurity","volume":"9","author":"Rani","year":"2016","journal-title":"Int. J. Control Theor. Appl."},{"key":"10.1016\/j.preteyeres.2021.101018_bib226","article-title":"Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity","author":"Redd","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib227","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1001\/archopht.120.11.1470","article-title":"Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies","volume":"120","author":"Reynolds","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib228","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.survophthal.2009.02.020","article-title":"Telemedicine for retinopathy of prematurity diagnosis: evaluation and challenges","volume":"54","author":"Richter","year":"2009","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib229","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00006982-200404000-00009","article-title":"Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity","volume":"24","author":"Rush","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ajo.2012.07.012","article-title":"Aggressive posterior retinopathy of prematurity: risk factors for retinal detachment despite confluent laser photocoagulation","volume":"155","author":"Sanghi","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib231","first-page":"CD009734","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preteyeres.2021.101018_bib232","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib233","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000486751","article-title":"Oxygenation of the immature infant: a commentary and recommendations for oxygen saturation targets and alarm limits","volume":"114","author":"Saugstad","year":"2018","journal-title":"Neonatology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib234","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000356561","article-title":"Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies","volume":"105","author":"Saugstad","year":"2014","journal-title":"Neonatology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib235","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/jama.2013.5555","article-title":"Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial","volume":"309","author":"Schmidt","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.preteyeres.2021.101018_bib236","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1542\/peds.2010-2873","article-title":"Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists","volume":"127","author":"Schulman","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib237","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0161-6420(95)31035-4","article-title":"Long-term visual results of children after initially successful vitrectomy for stage V retinopathy of prematurity","volume":"102","author":"Seaber","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib238","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/tjo.tjo_61_18","article-title":"Stage 5 retinopathy of prematurity: an update","volume":"8","author":"Sen","year":"2018","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib239","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4103\/ijo.IJO_1030_17","article-title":"Surgical outcomes of microincision vitrectomy surgery in eyes with retinal detachment secondary to retinopathy of prematurity in Indian population","volume":"67","author":"Sen","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib240","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41433-019-0643-4","article-title":"Retinopathy of prematurity treatment: asian perspectives","volume":"34","author":"Sen","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2021.101018_bib241","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.eye.6702939","article-title":"Anatomical and visual outcome of stages 4 and 5 retinopathy of prematurity","volume":"23","author":"Shah","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2021.101018_bib242","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00006982-200302000-00033","article-title":"ROP Photographic Screening Trial (Photo-ROP) Study Group. Inadvertent skip areas in treatment of zone 1 retinopathy of prematurity","volume":"23","author":"Shaikh","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib243","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.jinf.2013.09.011","article-title":"Neonatal sepsis: progress towards improved outcomes","volume":"68","author":"Shane","year":"2014","journal-title":"J. Infect."},{"key":"10.1016\/j.preteyeres.2021.101018_bib244","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41433-020-0888-y","article-title":"Brolucizumab-another anti-VEGF or beyond","volume":"34","author":"Sharma","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2021.101018_bib245","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajo.2019.03.027","article-title":"Retrospective validation of the postnatal growth and retinopathy of prematurity (G-ROP) criteria in a Japanese cohort","volume":"205","author":"Shiraki","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib246","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.4103\/ijo.IJO_1827_19","article-title":"Operational guidelines for ROP in India: a summary","volume":"68","author":"Shukla","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib247","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/bjophthalmol-2011-301353","article-title":"Long-term visual outcomes following lens-sparing vitrectomy for retinopathy of prematurity","volume":"96","author":"Singh","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib248","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archopht.1984.01040030289020","article-title":"Angle-closure glaucoma in adults with cicatricial retinopathy of prematurity","volume":"102","author":"Smith","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib249","first-page":"225","article-title":"Retinopathy of prematurity: late complications in the baby boomer generation (1946-1964","volume":"103","author":"Smith","year":"2005","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2021.101018_bib250","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0161-6420(90)32607-6","article-title":"Surgical management of late-onset retinal detachments associated with regressed retinopathy of prematurity","volume":"97","author":"Sneed","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib251","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/IAE.0b013e3181744136","article-title":"Macular structure and vision of patients with macular heterotopia secondary to retinopathy of prematurity","volume":"28","author":"Soong","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib252","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jamapediatrics.2017.4838","article-title":"Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial","volume":"172","author":"Stahl","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.preteyeres.2021.101018_bib253","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2021.101018_bib254","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012","volume":"314","author":"Stoll","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.preteyeres.2021.101018_bib255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00417-016-3443-6","article-title":"Treatment for stage 4A retinopathy of prematurity: laser and\/or ranibizumab","volume":"255","author":"Sukgen","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib256","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1651-2227.2009.01612.x","article-title":"Pain management during eye examinations for retinopathy of prematurity in preterm infants: a systematic review","volume":"99","author":"Sun","year":"2010","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.preteyeres.2021.101018_bib257","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.105.2.295","article-title":"A randomized, controlled trial. I: primary outcomes","volume":"105","author":"Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (Stop-Rop)","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib258","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa0911781","article-title":"Target ranges of oxygen saturation in extremely preterm infants","volume":"362","author":"Support Study Group of the Eunice Kennedy Shriver Nichd Neonatal Research Network","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2021.101018_bib259","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jaapos.2016.07.168","article-title":"Characterization of errors in retinopathy of prematurity (ROP) diagnosis by ophthalmology residents","volume":"20","author":"Swamy","year":"2016","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.preteyeres.2021.101018_bib316","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000499361","article-title":"European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update","volume":"115","author":"Sweet","year":"2019","journal-title":"Neonatology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib261","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/s41433-019-0500-5","article-title":"Foveal abnormalities determined by optical coherence tomography angiography in children with history of retinopathy of prematurity","volume":"33","author":"Takagi","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2021.101018_bib262","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00417115","article-title":"Retinal detachment in retrolental fibroplasia","volume":"195","author":"Tasman","year":"1975","journal-title":"Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib263","first-page":"367","article-title":"Progressive visual loss in adults with retinopathy of prematurity (ROP)","volume":"86","author":"Tasman","year":"1988","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2021.101018_bib264","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajo.2005.07.034","article-title":"Retinopathy of prematurity: the life of a lifetime disease","volume":"141","author":"Tasman","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib265","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamaophthalmol.2019.2433","article-title":"Monitoring disease progression with a quantitative severity scale for retinopathy of prematurity using deep learning","volume":"137","author":"Taylor","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib266","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0021-5155(03)00088-1","article-title":"Late-onset retinal detachment associated with regressed retinopathy of prematurity","volume":"47","author":"Terasaki","year":"2003","journal-title":"Jpn. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.preteyeres.2021.101018_bib267","doi-asserted-by":"crossref","DOI":"10.3390\/nu11010112","article-title":"Temporal progression of fatty acids in preterm and term human milk of mothers from Switzerland","volume":"11","author":"Thakkar","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.preteyeres.2021.101018_bib268","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3928\/23258160-20161130-02","article-title":"Spectral-domain optical coherence tomography in older patients with history of retinopathy of prematurity","volume":"47","author":"Thanos","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib269","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1053\/siny.2002.0130","article-title":"Giving small babies oxygen: 50 years of uncertainty","volume":"7","author":"Tin","year":"2002","journal-title":"Semin. Neonatol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib270","doi-asserted-by":"crossref","first-page":"F106","DOI":"10.1136\/fn.84.2.F106","article-title":"Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation","volume":"84","author":"Tin","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.preteyeres.2021.101018_bib271","doi-asserted-by":"crossref","first-page":"100759","DOI":"10.1016\/j.preteyeres.2019.04.003","article-title":"Deep learning in ophthalmology: the technical and clinical considerations","volume":"72","author":"Ting","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101018_bib272","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0161-6420(86)33681-9","article-title":"Visual results and prognostic factors for vision following surgery for stage V retinopathy of prematurity","volume":"93","author":"Trese","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib273","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ophtha.2020.11.012","article-title":"Neurodevelopmental outcomes after bevacizumab treatment for retinopathy of prematurity: a meta-analysis","volume":"128","author":"Tsai","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib274","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bjo.2003.022962","article-title":"Late onset vitreoretinal complications of regressed retinopathy of prematurity","volume":"88","author":"Tufail","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib275","article-title":"Evaluation of birth weight and gestational age in infants with treatment requiring retinopathy of prematurity in ROPE-SOS trial","volume":"59","author":"Valikodath","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101018_bib276","first-page":"178","article-title":"Imaging in retinopathy of prematurity","volume":"8","author":"Valikodath","year":"2019","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.preteyeres.2021.101018_bib277","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.semperi.2019.05.011","article-title":"Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity","volume":"43","author":"Vanderveen","year":"2019","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib278","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaapos.2011.07.017","article-title":"Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial","volume":"15","author":"Vanderveen","year":"2011","journal-title":"J Aapos"},{"key":"10.1016\/j.preteyeres.2021.101018_bib279","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","article-title":"Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of ophthalmology","volume":"124","author":"Vanderveen","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib280","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1978","article-title":"Trends in the screening and treatment of retinopathy of prematurity","volume":"139","author":"Vartanian","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2021.101018_bib281","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/s-0036-1597131","article-title":"Parenteral fish-oil lipid emulsions in the prevention of severe retinopathy of prematurity: a systematic review and meta-analysis","volume":"34","author":"Vayalthrikkovil","year":"2017","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib282","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4103\/ijo.IJO_852_19","article-title":"The Indian Retinopathy of Prematurity (iROP) society: challenges ahead","volume":"67","author":"Vinekar","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib283","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0301-4738.126178","article-title":"The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide-field imaging, tele-medicine, non-physician graders and smart phone reporting","volume":"62","author":"Vinekar","year":"2014","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib284","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/EB.S98715","article-title":"Impact of improved neonatal care on the profile of retinopathy of prematurity in rural neonatal centers in India over a 4-year period","volume":"8","author":"Vinekar","year":"2016","journal-title":"Eye Brain"},{"key":"10.1016\/j.preteyeres.2021.101018_bib285","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.8.2.2","article-title":"A novel, low-cost, wide-field, infant retinal camera, \"Neo\": technical and safety report for the use on premature infants","volume":"8","author":"Vinekar","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib286","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaapos.2007.04.008","article-title":"A pilot study using \"ROPtool\" to quantify plus disease in retinopathy of prematurity","volume":"11","author":"Wallace","year":"2007","journal-title":"J Aapos"},{"key":"10.1016\/j.preteyeres.2021.101018_bib287","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jamaophthalmol.2017.1055","article-title":"Assessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity: a phase 1 dosing study","volume":"135","author":"Wallace","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib288","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.ophtha.2018.05.001","article-title":"A dosing study of bevacizumab for retinopathy of prematurity: late recurrences and additional treatments","volume":"125","author":"Wallace","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib289","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamaophthalmol.2020.0334","article-title":"Short-term outcomes after very low-dose intravitreous bevacizumab for retinopathy of prematurity","volume":"138","author":"Wallace","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib290","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archophthalmol.2012.1890","article-title":"Improving preterm ophthalmologic care in the era of accountable care organizations","volume":"130","author":"Wang","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib291","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcjo.2014.11.005","article-title":"SUNDROP: six years of screening for retinopathy of prematurity with telemedicine","volume":"50","author":"Wang","year":"2015","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib292","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ebiom.2018.08.033","article-title":"Automated retinopathy of prematurity screening using deep neural networks","volume":"35","author":"Wang","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.preteyeres.2021.101018_bib293","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/09286586.2019.1585885","article-title":"Retinopathy of prematurity in Africa: a systematic review","volume":"26","author":"Wang","year":"2019","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib294","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.earlhumdev.2007.12.004","article-title":"UK retinopathy of prematurity guideline","volume":"84","author":"Wilkinson","year":"2008","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.preteyeres.2021.101018_bib295","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/archopht.118.3.438","article-title":"A macular lesion simulating an aberrant cryotherapy lesion in retinopathy of prematurity","volume":"118","author":"Williams","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib296","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1167\/iovs.07-1353","article-title":"Computerized analysis of retinal vessel width and tortuosity in premature infants","volume":"49","author":"Wilson","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101018_bib297","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clp.2013.02.003","article-title":"The challenge of screening for retinopathy of prematurity","volume":"40","author":"Wilson","year":"2013","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib298","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaapos.2011.12.154","article-title":"Training fellows for retinopathy of prematurity care: a Web-based survey","volume":"16","author":"Wong","year":"2012","journal-title":"J Aapos"},{"key":"10.1016\/j.preteyeres.2021.101018_bib299","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/IAE.0000000000000578","article-title":"Reactivation of retinopathy of prematurity after ranibizumab treatment","volume":"35","author":"Wong","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib300","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/17434440.2016.1208560","article-title":"Evaluation of Visunex Medical's PanoCam(TM) LT and PanoCam(TM) Pro wide-field imaging systems for the screening of ROP in newborn infants","volume":"13","author":"Wood","year":"2016","journal-title":"Expet Rev. Med. Dev."},{"key":"10.1016\/j.preteyeres.2021.101018_bib301","series-title":"Recommendations on Interventions to Improve Preterm Birth Outcomes","first-page":"98","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.preteyeres.2021.101018_bib302","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.ophtha.2012.02.040","article-title":"Visual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurity","volume":"119","author":"Wu","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2021.101018_bib303","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajo.2012.06.010","article-title":"An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan","volume":"155","author":"Wu","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib304","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jamaophthalmol.2013.5052","article-title":"Choroidal thickness in patients with a history of retinopathy of prematurity","volume":"131","author":"Wu","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib305","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamaophthalmol.2014.5373","article-title":"Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity","volume":"133","author":"Wu","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2021.101018_bib306","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/IAE.0000000000001209","article-title":"Serum vascular endothelial growth factor After bevacizumab or ranibizumab treatment for retinopathy OF prematurity","volume":"37","author":"Wu","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib307","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1167\/iovs.13-12297","article-title":"Screening for retinopathy of prematurity in China: a neonatal units-based prospective study","volume":"54","author":"Xu","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2021.101018_bib308","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaapos.2005.08.005","article-title":"Retinopathy of prematurity in infants with birth weight>or=1250 grams-incidence, severity, and screening guideline cost-analysis","volume":"10","author":"Yanovitch","year":"2006","journal-title":"J Aapos"},{"key":"10.1016\/j.preteyeres.2021.101018_bib309","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3109\/02713683.2015.1084643","article-title":"Effects of intravitreal ranibizumab in the treatment of retinopathy of prematurity in Chinese infants","volume":"41","author":"Yi","year":"2016","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2021.101018_bib310","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1136\/bjophthalmol-2017-311576","article-title":"Association of antenatal steroid and risk of retinopathy of prematurity: a systematic review and meta-analysis","volume":"102","author":"Yim","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib311","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/IAE.0000000000001685","article-title":"Progressive retinal detachment IN infants with retinopathy OF prematurity treated with intravitreal bevacizumab or ranibizumab","volume":"38","author":"Yonekawa","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib313","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archophthalmol.2012.215","article-title":"Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Mexican population of preterm infants","volume":"130","author":"Zepeda-Romero","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2021.101018_bib314","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/IAE.0000000000001241","article-title":"Comparison OF intravitreal injection OF ranibizumab versus laser therapy for zone II treatment-requiring retinopathy OF prematurity","volume":"37","author":"Zhang","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2021.101018_bib315","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1542\/peds.2010-0090","article-title":"Retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload implications","volume":"126","author":"Zin","year":"2010","journal-title":"Pediatrics"}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946221000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946221000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:41:50Z","timestamp":1761172910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946221000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":313,"alternative-id":["S1350946221000793"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2021.101018","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2021.101018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101018"}}